254 related articles for article (PubMed ID: 24147047)
1. Relationship of CHA2DS2-VASc and CHADS2 score to left atrial remodeling detected by velocity vector imaging in patients with atrial fibrillation.
Li Y; Ding W; Wang H; Song N; Lin L; Wang Z; Zhong M; Zhang Y; Zhang W
PLoS One; 2013; 8(10):e77653. PubMed ID: 24147047
[TBL] [Abstract][Full Text] [Related]
2. Left atrial spontaneous echo contrast occurring in patients with low CHADS
Akamatsu K; Ito T; Ozeki M; Miyamura M; Sohmiya K; Hoshiga M
Cardiovasc Ultrasound; 2020 Aug; 18(1):31. PubMed ID: 32738924
[TBL] [Abstract][Full Text] [Related]
3. Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation.
Chen YY; Liu Q; Liu L; Shu XR; Su ZZ; Zhang HF; Nie RQ; Wang JF; Xie SL
Chin Med J (Engl); 2016 Oct; 129(20):2395-2402. PubMed ID: 27748329
[TBL] [Abstract][Full Text] [Related]
4. Correlation between cardiac rhythm, left atrial appendage flow velocity, and CHA
Zuo K; Sun L; Yang X; Lyu X; Li K
Clin Cardiol; 2017 Feb; 40(2):120-125. PubMed ID: 28075503
[TBL] [Abstract][Full Text] [Related]
5. Association of CHADS2, CHA2DS2-VASc, and R2CHADS2 scores with left atrial dysfunction in patients with coronary heart disease (from the Heart and Soul study).
Azarbal F; Welles CC; Wong JM; Whooley MA; Schiller NB; Turakhia MP
Am J Cardiol; 2014 Apr; 113(7):1166-72. PubMed ID: 24507169
[TBL] [Abstract][Full Text] [Related]
6. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
7. Association of CHADS
Huang J; Wu SL; Xue YM; Fei HW; Lin QW; Ren SQ; Liao HT; Zhan XZ; Fang XH; Xu L
Biomed Res Int; 2017; 2017():6839589. PubMed ID: 28373985
[TBL] [Abstract][Full Text] [Related]
8. Relationship between CHA2DS2-VASc score and atrial electromechanical function in patients with paroxysmal atrial fibrillation: A pilot study.
Vatan MB; Yılmaz S; Ağaç MT; Çakar MA; Erkan H; Aksoy M; Demirtas S; Varım C; Akdemir R; Gündüz H
J Cardiol; 2015 Nov; 66(5):382-7. PubMed ID: 25818642
[TBL] [Abstract][Full Text] [Related]
9. The Value of the CHADS
Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449
[TBL] [Abstract][Full Text] [Related]
10. Improvement of Predictive Value for Thromboembolic Risk by Incorporating Left Atrial Functional Parameters in the CHADS2 and CHA2DS2-VASc Scores.
Kim MN; Kim SA; Choi JI; Park SM; Park SW; Kim YH; Shim WJ
Int Heart J; 2015 May; 56(3):286-92. PubMed ID: 25912904
[TBL] [Abstract][Full Text] [Related]
11. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
[TBL] [Abstract][Full Text] [Related]
12. Relation of red blood cell distribution width with CHADS
Liu T; Shao Q; Korantzopoulos P; Miao S; Zhang Z; Xu G; Yuan R; Li G
Int J Cardiol; 2017 Feb; 228():861-864. PubMed ID: 27889552
[TBL] [Abstract][Full Text] [Related]
13. Refinement of CHADS2 and CHA2DS2-VASc scores predict left atrial thrombus or spontaneous echo contrast in nonvalvular atrial fibrillation patients.
Cao M; Guo H; Zhao X; Li X; Sun C
J Int Med Res; 2022 Jan; 50(1):3000605221074520. PubMed ID: 35196885
[TBL] [Abstract][Full Text] [Related]
14. Association of the CHADS2 and CHA 2DS 2-VASc scores with left atrial enlargement: a prospective cohort study of unselected atrial fibrillation patients.
Hrynkiewicz-Szymanska A; Dluzniewski M; Platek AE; Szymanski FM; Syska-Suminska J; Klos-Szadryn A; Glinka M; Strojek M; Kuciej A; Tomaszewska-Kiecana M
J Thromb Thrombolysis; 2015 Aug; 40(2):240-7. PubMed ID: 25490871
[TBL] [Abstract][Full Text] [Related]
15. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
16. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
17. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
[TBL] [Abstract][Full Text] [Related]
18. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
[TBL] [Abstract][Full Text] [Related]
19. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.
Komatsu T; Sato Y; Ozawa M; Kunugita F; Yoshizawa R; Morino Y; Nakamura M
Int Heart J; 2014; 55(2):119-25. PubMed ID: 24632957
[TBL] [Abstract][Full Text] [Related]
20. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
